Log In

Part Description

LP420287-7   Tocilizumab
Tocilizumab is a recombinant humanized monoclonal antibody against the interleukin-6 receptor being used to treat patients with COVID-19 pneumonia. Such patients are in danger of developing a hyperimmune response known as a cytokine storm which is characterized by an increased production of cytokines. The cytokines cause damage and lung tissue fibrosis that can last an extensive amount of time. The current treatment for COVID-19 includes the use of anti-viral and immunomodulatory drugs, including tocilizumab. Tocilizumab is also used to treat severe rheumatoid arthritis, systemic juvenile idiopathic arthritis, giant cell arteritis, and life-threatening cytokine release syndrome induced by chimeric antigen receptor T cell therapy.https://www.thelancet.com/journals/lanrhe/article/PIIS2665-9913(20)30173-9/fulltext Source: Regenstrief LOINC

LOINC Names Get Info

Fully-Specified Name
Tocilizumab:MCnc:Pt:Ser:Qn:
Long Common Name
Tocilizumab [Mass/volume] in Serum
Short Name
Tocilizumab Ser-mCnc
Display Name
Tocilizumab (S) [Mass/Vol]
Consumer Name Alpha Get Info
Tocilizumab, Blood

Part Model Get Info

  • Component
    Tocilizumab
    LP420287-7
    • Analyte
      Tocilizumab
      LP420287-7
      • Component Numerator
        Tocilizumab
        LP420287-7
        • Component Numerator Core
          Tocilizumab
          LP420287-7
        • Component Numerator Core Suffix
          NULL
           
      • Component Denominator
        NULL
         
        • Component Denominator Core
          NULL
           
        • Component Denominator Core Suffix
          NULL
           
    • Challenge
      NULL
       
    • Adjustment
      NULL
       
    • Count
      NULL
       
  • Property
    MCnc
    LP6827-2
  • Time
    Pt
    LP6960-1
  • System
    Ser
    LP7567-3
    • System Core
      Ser
      LP7567-3
    • Super System
      NULL
       
  • Scale
    Qn
    LP7753-9
  • Method
    NULL
     

Basic Attributes

Class
DRUG/TOX
Type
Laboratory
First Released
Version 2.69
Last Updated
Version 2.69 (ADD)
Order vs. Observation
Both

Language Variants Get Info

TagLanguageTranslation
cs-CZCzech (Czechia)Tocilizumab:Hmotnostní koncentrace:Časový bod:Sérum:Kvantitativní:
el-GRGreek (Greece)Τοσιλιζουμάμπη:MCnc:Pt:Ορός:Qn:
Synonyms: DRUG/TOX MCnc Pt Qn Ορός Τοσιλιζουμάμπη
es-ESSpanish (Spain)Tocilizumab:Concentración de masa:Punto temporal:Suero:Qn:
Synonyms: Cuantitativo
es-MXSpanish (Mexico)Tocilizumab:Concentración de masa:Punto temporal:Suero:Cuantitativo:
fr-FRFrench (France)Tocilizumab:Masse/Volume:Ponctuel:Sérum:Numérique:
it-ITItalian (Italy)Tocilizumab:MCnc:Pt:Siero:Qn:
Synonyms: Concentrazione di Massa Livelli farmacologici e tossicologia Punto nel tempo (episodio) Siero
nl-NLDutch (Netherlands)tocilizumab:massa/volume:moment:serum:kwantitatief:
zh-CNChinese (China)托珠单抗:质量浓度:时间点:血清:定量型:
Synonyms: 免疫球蛋白IgG1(γ1，κ)子类重组人源化抗-人白介素6(IL-6)受体单抗;雅美罗;IL-6受体单抗;Actemra;IL-6受体抑制剂;托珠单抗 可用数量表示的;定量性;数值型;数量型;连续数值型标尺 时刻;随机;随意;瞬间 毒品 毒品类 水平;浓度;质量浓度(单位体积) 药品类 药物 药物/毒理学;药物/毒理学试验;药物毒理学试验;药物毒理学试验类 药物类

Example Units

UnitSource
ug/mLExample UCUM Units

LOINC Terminology Service (API) using HL7® FHIR® Get Info

CodeSystem lookup
https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=95922-1